UnitedHealth Group Incorporated (UNH) Receives $201.71 Consensus Target Price from Analysts
Shares of UnitedHealth Group Incorporated (NYSE:UNH) have earned a consensus rating of “Buy” from the twenty-six analysts that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and twenty-four have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $201.71.
A number of equities analysts recently commented on UNH shares. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Cantor Fitzgerald reiterated a “buy” rating and issued a $205.00 price objective on shares of UnitedHealth Group in a report on Friday, July 7th. Credit Suisse Group reiterated an “outperform” rating and issued a $200.00 price objective (up previously from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Citigroup Inc. raised their target price on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $212.00 target price on shares of UnitedHealth Group in a research report on Thursday, July 20th.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the sale, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold 76,174 shares of company stock valued at $14,981,909 over the last three months. 0.89% of the stock is currently owned by corporate insiders.
Several hedge funds have recently modified their holdings of UNH. Honeywell International Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $35,262,000. Suntrust Banks Inc. raised its position in UnitedHealth Group by 8.5% in the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock worth $42,774,000 after acquiring an additional 20,541 shares in the last quarter. Factory Mutual Insurance Co. raised its position in UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after acquiring an additional 72,000 shares in the last quarter. Shell Asset Management Co. raised its position in UnitedHealth Group by 0.8% in the second quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock worth $29,156,000 after acquiring an additional 1,254 shares in the last quarter. Finally, Moody Lynn & Lieberson LLC raised its position in UnitedHealth Group by 569.9% in the second quarter. Moody Lynn & Lieberson LLC now owns 8,937 shares of the healthcare conglomerate’s stock worth $1,657,000 after acquiring an additional 7,603 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.
Shares of UnitedHealth Group (NYSE:UNH) traded up 0.60% during trading on Friday, reaching $198.63. 2,533,800 shares of the company were exchanged. The stock has a market capitalization of $192.05 billion, a P/E ratio of 23.86 and a beta of 0.63. The firm has a 50-day moving average price of $195.77 and a 200-day moving average price of $182.90. UnitedHealth Group has a 1-year low of $133.03 and a 1-year high of $200.76.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter in the previous year, the firm posted $1.96 earnings per share. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group will post $9.87 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.51%. The ex-dividend date of this dividend was Thursday, September 7th. UnitedHealth Group’s payout ratio is 35.13%.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.